Axsome Therapeutics Inc

NEW
STU:19X (USA)  
€ 180.45 -6 (-3.22%) Sep 18
At Loss
P/B:
136.99
Market Cap:
€ 9.48B ($ 10.89B)
Enterprise V:
€ 9.40B ($ 10.79B)
Volume:
100.00
Avg Vol (2M):
127.00
Trade In:
Volume:
100.00
At Loss

Axsome Therapeutics Inc (STU:19X) Dividend

Axsome Therapeutics Inc (STU:19X) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -5.4%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: STU:19X Dividend

Does Axsome Therapeutics Inc (STU:19X) pay a dividend?

Axsome Therapeutics Inc (STU:19X) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Axsome Therapeutics Inc pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Axsome Therapeutics Inc has returned capital to shareholders via buybacks at a rate of -5.4% over the past 3 years.

What are dividend-paying alternatives to Axsome Therapeutics Inc?

For dividend-paying alternatives in Axsome Therapeutics Inc's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.